CD34 is expressed on the surface of hematopoietic stem/progenitor cells, stromal cells, and on the surface of high-endothelial venules (HEV). CD34 binds L-selectin, an adhesion molecule important for leukocyte rolling on venules and lymphocyte homing to peripheral lymph nodes (PLN). We generated CD34-deficient mutant animals through the use of homologous recombination. Wild-type and mutant animals showed no differences in lymphocyte binding to PLN HEV, in leukocyte rolling on venules or homing to PLN, in neutrophil extravasation into peritoneum in response to inflammatory stimulus, nor in delayed type hypersensitivity. Anti-L-selectin monoclonal antibody (MEL-14) also inhibited these immune responses similarly in both CD34-deficient and wild-type mice. However, eosinophil accumulation in the lung after inhalation of a model allergen, ovalbumin, is several-fold lower in mutant mice. We found no abnormalities in hematopoiesis in adult mice and interactions between mutant progenitor cells and a stromal cell line in vitro were normal. No differences existed in the recovery of progenitor cells after 5-fluorouracil treatment, nor in the mobilization of progenitor cells after granulocyte colony-stimulating factor treatment compared with wild-type animals. Surprisingly, although CD34 was not expressed in these mice, a portion of its 90-kD band crossreactive with MECA79 remained after Western blot. Thus, we have identified an additional molecule(s) that might be involved in leukocyte trafficking. These results indicate that CD34 plays an important role in eosinophil trafficking into the lung.
Skip Nav Destination
ARTICLES|
May 1, 1996
CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein
A Suzuki,
A Suzuki
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
DP Andrew,
DP Andrew
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
JA Gonzalo,
JA Gonzalo
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
M Fukumoto,
M Fukumoto
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
J Spellberg,
J Spellberg
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
M Hashiyama,
M Hashiyama
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
H Takimoto,
H Takimoto
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
N Gerwin,
N Gerwin
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
I Webb,
I Webb
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
G Molineux,
G Molineux
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
R Amakawa,
R Amakawa
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
Y Tada,
Y Tada
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
A Wakeham,
A Wakeham
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
J Brown,
J Brown
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
I McNiece,
I McNiece
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
K Ley,
K Ley
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
EC Butcher,
EC Butcher
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
T Suda,
T Suda
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
JC Gutierrez-Ramos,
JC Gutierrez-Ramos
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
TW Mak
TW Mak
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, Toronto, Canada.
Search for other works by this author on:
Blood (1996) 87 (9): 3550–3562.
Citation
A Suzuki, DP Andrew, JA Gonzalo, M Fukumoto, J Spellberg, M Hashiyama, H Takimoto, N Gerwin, I Webb, G Molineux, R Amakawa, Y Tada, A Wakeham, J Brown, I McNiece, K Ley, EC Butcher, T Suda, JC Gutierrez-Ramos, TW Mak; CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood 1996; 87 (9): 3550–3562. doi: https://doi.org/10.1182/blood.V87.9.3550.bloodjournal8793550
Download citation file:
May 1 1996
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal